Cargando…

Big data, medicines safety and pharmacovigilance

Detalles Bibliográficos
Autor principal:	Hussain, Rabia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170061/ https://www.ncbi.nlm.nih.gov/pubmed/34078480 http://dx.doi.org/10.1186/s40545-021-00329-4

Ejemplares similares

Current status and future prospects of pharmacovigilance in Pakistan
por: Hussain, Rabia, et al.
Publicado: (2019)

Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013)

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018)

Pharmacoenvironmentology – a component of pharmacovigilance
por: Rahman, Syed Ziaur, et al.
Publicado: (2007)

An historical overview over Pharmacovigilance
por: Fornasier, Giulia, et al.
Publicado: (2018)

Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era
por: Ferreira-da-Silva, Renato, et al.
Publicado: (2021)

Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?
por: Chandler, Rebecca E.
Publicado: (2017)

Learning the effects of psychotropic drugs during pregnancy using real-world safety data: a paradigm shift toward modern pharmacovigilance
por: Lupattelli, Angela, et al.
Publicado: (2018)

Informatics applied to pharmacovigilance: Future perspectives
por: Menniti, Michele, et al.
Publicado: (2013)

Big knowledge from big data in functional genomics
por: Ponting, Chris P.
Publicado: (2017)

Epidemiology and ‘big data’
por: Stricker, Bruno H.
Publicado: (2017)

Pharmacovigilance strategy: opportunities for cross-national learning
por: Fermont, Irene
Publicado: (2019)

Commentary: Big data in Ophthalmology: A big game changer on horizon
por: Kumar, Nilesh, et al.
Publicado: (2021)

Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
por: Kurz, Xavier, et al.
Publicado: (2018)

Big data in healthcare: are we close to it?
por: Naidus, Elliot, et al.
Publicado: (2016)

Family studies in the age of big data
por: Almasy, Laura
Publicado: (2022)

EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018)

Mobility - Big Data Isn't always Big
por: Sigismund, Markus
Publicado: (2021)

Pharmacovigilance: Safety matters…
por: Biswas, Pipasha
Publicado: (2008)

The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic
por: Ogar, C., et al.
Publicado: (2020)

Sharing Big Data
por: Grabowski, Marek, et al.
Publicado: (2017)

Codifying healthcare – big data and the issue of misclassification
por: Ladha, Karim S., et al.
Publicado: (2015)

Is dementia research ready for big data approaches?
por: Hofmann-Apitius, Martin
Publicado: (2015)

Big Data in radiation therapy: challenges and opportunities
por: Lustberg, Tim, et al.
Publicado: (2017)

Artificial Intelligence and Big Data in Public Health
por: Benke, Kurt, et al.
Publicado: (2018)

Scalable biclustering — the future of big data exploration?
por: Orzechowski, Patryk, et al.
Publicado: (2019)

Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD
por: Ambrosio, Giuseppe, et al.
Publicado: (2019)

Scoring Lifestyle Medicine Goals With FIFA 2022—An Opportunity to Strike Big!
por: Doraiswamy, Sathyanarayanan, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion
por: Yamoah, Peter, et al.
Publicado: (2020)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Big Pharma, Big Bucks, and a Big Pile o' Pigs
Publicado: (2001)

Digital Pharmacovigilance and Disease Surveillance: Combining Traditional and Big-Data Systems for Better Public Health
por: Salathé, Marcel
Publicado: (2016)

Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment
por: Naniche, Denise, et al.
Publicado: (2021)

Pharmacovigilance of ayurvedic medicines in India
por: Thatte, Urmila, et al.
Publicado: (2008)

Integrating big data and actionable health coaching to optimize wellness
por: Hood, Leroy, et al.
Publicado: (2015)

Using big data to track major shifts in human cognition
por: DeDeo, Simon
Publicado: (2022)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Big data and data repurposing - using existing data to answer new questions in vascular dementia research
por: Doubal, Fergus N., et al.
Publicado: (2017)

Paediatric big data and analytics to improve the management of infectious diseases in children
por: Okomo, Uduak
Publicado: (2022)

Common data elements and minimum data sets in cerebral palsy: Start small to grow big
por: Dieterich, Klaus
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nnag27qijsg97vgesu1nsf9scn